Characteristics of patients with ITP included in the study
| Baseline characteristics∗ . | Patients with ITP (n = 24) . |
|---|---|
| Age in y, median† (range) | 60 (36-90) |
| Male (%)† | 57 |
| Platelet count, median (range) | 66 (2-459) |
| Years since diagnosis of ITP, median (range)† | 8 (0-58) |
| Newly diagnosed or persistent (0-12 mo), n (%) | 5 (22%) |
| Chronic (>12 mo), n (%) | 18 (78%) |
| Number of previous therapies, median† (range) | 3 (0-10) |
| Splenectomized† (%) | 26% |
| IVIg treated (n)‡ | 15 |
| IVIg responsive (%) | 73% |
| Baseline characteristics∗ . | Patients with ITP (n = 24) . |
|---|---|
| Age in y, median† (range) | 60 (36-90) |
| Male (%)† | 57 |
| Platelet count, median (range) | 66 (2-459) |
| Years since diagnosis of ITP, median (range)† | 8 (0-58) |
| Newly diagnosed or persistent (0-12 mo), n (%) | 5 (22%) |
| Chronic (>12 mo), n (%) | 18 (78%) |
| Number of previous therapies, median† (range) | 3 (0-10) |
| Splenectomized† (%) | 26% |
| IVIg treated (n)‡ | 15 |
| IVIg responsive (%) | 73% |